Late-stage pharmaceutical company advancing Bivante, a DMA-free IV busulfan formulation for stem cell transplant conditioning, on a defined 505(b)(2) regulatory path.
Download Project Emerald ↓
Industry
Pharma / Biotech
Headquarters
Houston, TX
Market
>$300M annual
Capital Sought
$5.0mm Series B
Project Emerald — Investment Teaser Open in New Tab ↗ Download ↓
Loading the teaser… if it does not appear, use “Open in New Tab” or “Download” above.
Strictly confidential
Prepared by Intelligentzia Capital Management
Scroll within the frame to navigate pages
Discuss This Project
Explore Project Emerald
Contact our team to receive additional information under NDA.
Contact Us → All Opportunities
📌 Project Emerald (Río Cuarto)
🏢 Intelligentzia Capital Management
📍 Río Cuarto
Postulate a este anuncio
Muestra tus habilidades a la empresa, rellenar el formulario y deja un toque personal en la carta, ayudará el reclutador en la elección del candidato.